Talk:Zoledronic acid

Kidney disease?
The article says: "Zoledronate is rapidly processed via the kidneys; consequently its administration is not recommended for patients with reduced renal function or kidney disease." I'm sure this is true of almost any drugs, but some casual clicking around in Medline and elsewhere didn't turn up anything like this. For example, this article says "tell your doctor if you are being treated wtih radiation therapy and if you have or have ever had heart failure (condition in which the heart cannot pump enough blood to other parts of the body); anemia (condition in which red blood cells cannot bring enought oxygen to the other parts of the body); any condition that stops your blood from clotting normally; problems with your mouth, teeth, or gums; an infection, especially in your mouth; asthma, especially if it is made worse by aspirin; or kidney or liver disease" I'd think almost any drug might stress the kidneys and I'd think any patient ought to tell their doctor about kidney or liver disease before starting any significant course of drug treatment. The article seems to imply that zoledronate has a special risk, requiring a special caution. I have no reason to doubt this, but I'd like to see a citation. Dpbsmith (talk) 15:55, 1 April 2008 (UTC)


 * Renal toxicity is an issue for all bisphosphonates as the non bone-binding drug is rapidly cleared by the kidneys. Thus they all have the standard warning regarding patients with compromised kidney function. Here is a citation for a ZA specific report that shows renal impairment in 23.8% of patients.

Oh WK, Proctor K, Nakabayashi M, Evan C, Tormey LK, Daskivich T, Antràs L, Smith M, Neary MP, Duh MS. The risk of renal impairment in hormone-refractory prostate cancer patients with bone metastases treated with zoledronic acid. Cancer. 2007 Mar 15;109(6):1090-6. PMID: 17311345 Dr Aaron (talk) 13:30, 2 April 2008 (UTC)

Use in cancer therapy
There is talk of using this drug (and bisphosphonates in general) in the treatment of breast cancer. See: http://www.nytimes.com/2009/02/12/health/research/12bone.html —Preceding unsigned comment added by 86.219.3.19 (talk) 09:29, 19 December 2009 (UTC)
 * This is mentioned in the Research section. Rod57 (talk) 14:03, 4 May 2011 (UTC)


 * A TED talk by David Agnus mentions this, and a TED talk by Mina Bissel suggests cancer is related to the extra cellular matrix or 'architecture' around the cell becoming damaged and failing to constrict its activity Timpo (talk) 12:53, 29 January 2014 (UTC)


 * thank you but TED talks are not OK sources under WP:MEDRS. Jytdog (talk) 13:50, 29 January 2014 (UTC)

Need a secondary link
These links can be found in a number of recent articles in the review part, but I did not find for them the separate (secondary) review. If anyone knows of a secondary link, please give.

Intravenous administration of Zoledronic acid leads to the production of ApppI (a non-hydrolysable ATP analogue), which is cytotoxic, and inhibits the mitochondrial adenine nucleotide translocase that leads to direct activation of mitochondrial apoptosis     Dmitry Dzhagarov (talk) 09:11, 25 March 2016 (UTC)

External links modified
Hello fellow Wikipedians,

I have just modified 1 one external link on Zoledronic acid. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:
 * Added archive http://web.archive.org/web/20100423105839/http://www.nps.org.au:80/consumers/publications/medicine_update/issues/zoledronic_acid to http://www.nps.org.au/consumers/publications/medicine_update/issues/Zoledronic_acid

When you have finished reviewing my changes, please set the checked parameter below to true or failed to let others know (documentation at ).

Cheers.— InternetArchiveBot  (Report bug) 23:34, 20 July 2016 (UTC)

A history section for dates
We could have a History section for rough dates of pivotal trials, and dates of various FDA, EMA etc approvals. (Two FDA approvals seems to have been in August 2001, and March 2003) - Rod57 (talk) 15:50, 22 November 2017 (UTC)